Pathology Grand Rounds - FDA Guidance for Reducing Risk for Disease Transmission: Blood Versus Cellular Therapy

During this activity, participants will learn:

* Updates to FDA guidance recommendations for blood and blood components due to need to increase blood supply

* Key differences in FDA guidance recommendations regarding disease transmission for blood and blood components and human tissue and cellular products

* Risk of disease transmission from blood and cellular products